Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Guidelines for implementing antiretroviral therapy].

M Sarcletti1, R Zangerle

  • 1HIV-Bereich, Universitätsklinik für Dermatologie und Venerologie, Innsbruck.

Wiener Medizinische Wochenschrift (1946)
|April 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.

HIV medicine·2020
Same author

Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection.

HIV medicine·2017
Same author

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

HIV medicine·2017
Same author

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

HIV medicine·2016
Same author

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.

HIV medicine·2016
Same author

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Expert supervision is crucial for managing complex HIV treatment. Early and asymptomatic HIV infection treatment aims for maximum viral suppression, monitored by viral RNA levels and CD4 counts.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Virology

Context:

  • The increasing complexity of managing HIV infection necessitates expert-guided care.
  • Antiretroviral therapy (ART) has evolved significantly, requiring updated treatment guidelines.

Purpose:

  • To provide recommendations for the treatment of HIV-infected individuals.
  • To outline goals and monitoring strategies for antiretroviral therapy.
  • To emphasize the importance of patient adherence and education in HIV management.

Summary:

  • Treatment is recommended for acute and symptomatic HIV infection.
  • For asymptomatic patients, treatment decisions consider adherence, prognosis, and patient willingness.
  • The primary goal of ART is sustained maximum viral suppression, evidenced by undetectable plasma HIV RNA levels.

Related Experiment Videos

  • Therapy success is evaluated by a one-log decrease in viral RNA at 8 weeks and undetectable levels by 4-6 months.
  • Potential treatment failures include nonadherence, drug resistance, and suboptimal drug levels.

    • Impact:

    • Optimizing HIV treatment strategies can lead to improved patient outcomes and reduced disease progression.
    • Effective viral suppression is key to preventing opportunistic infections and improving quality of life for individuals with HIV.
    • Understanding factors influencing treatment success and failure aids in refining clinical practice and patient care for HIV.